Dr Armel Martin Zemsi Kala
| Call | EDCTP Clinical Research & Development Fellowship (R&D F) |
| Programme | EDCTP2 |
| Start Date | 2017-05-01 |
| End Date | 2018-10-28 |
| Project Code | TMA2015-1168 |
| Status | Active |
Title
Janssen Pharmaceutica NV, Beerse, Belgium
Objectives
The main objective is to gain knowledge and practical expertise in many aspects in the set up and conduct of a clinical trial in SSA and to bring back the knowledge to the Home institution.
Host Organisation
| Institution | Country |
|---|---|
| Jassen Pharmaceutica NV, Beerse | Belgium |
| The Bamenda Center for Health Promotion and Research | Cambodia |
Study Design
12 months placement at Janssen, and 6 month reintegration at home institution.
Current Organisation
MRCG at LSHTM
Current Job Title
Head Clinical Trials Unit
Awards
| 2020 | Grant by Johnson & Johnson to conduct the CONSENT study (Comparing novel method of consent administration to standard approach in enhancing trial understanding in resource limited settings: A Randomized Trial) |
Students Supervised
| Type | Name | Title | University | Start Date | End Date |
|---|---|---|---|---|---|
| Armel Zemsi |
Memberships
| Role | Committee/board | Start Date | End Date |
|---|---|---|---|
| Member | Scientific Coordinating Committee in The Gambia | 2023 | 2023 |
Education
| Institution | Degree | Year |
|---|---|---|
| LSHTM, United Kingdom | Masters in Clinical Trials | 2020-11-01 |
| Faculty of Medicine and of Biomedical Sciences of the University of Yaounde I, | Medical Doctorate | 2014-10-15 |
Areas Of Specialisation
Tuberculosis (TB) Malaria Neglected Infectious Diseases (NID)